Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

Por Isabelle Ray-Coquard, Hélène Vanacker, Olivia Le Saux, Olivier Tredan
Publicado em 2020-11-01

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer

Por Coralie Poulard, Julien Jacquemetton, Olivier Trédan, Pascale A. Cohen, Julie Vendrell, Sandra E. Ghayad, Isabelle Treilleux, Elisabetta Marangoni, Muriel Le Romancer
Publicado em 2019-06-01

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

Por Patrick Arnaud-Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Tredan, Valery Attignon, Daniel Pissaloux, Emilie Sohier, Philippe Cassier, Gwenaelle Garin, David Pérol, Jean-Yves Blay, Armelle Dufresne
Publicado em 2020-12-01